MnTE-2-PyP Suppresses Prostate Cancer Cell Growth via H<sub>2</sub>O<sub>2</sub> Production
Prostate cancer patients are often treated with radiotherapy. MnTE-2-PyP, a superoxide dismutase (SOD) mimic, is a known radioprotector of normal tissues. Our recent work demonstrated that MnTE-2-PyP also inhibits prostate cancer progression with radiotherapy; however, the mechanisms remain unclear....
Main Authors: | Yuxiang Zhu, Elizabeth A. Kosmacek, Arpita Chatterjee, Rebecca E. Oberley-Deegan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/6/490 |
Similar Items
-
The Metalloporphyrin Antioxidant, MnTE-2-PyP, Inhibits Th2 Cell Immune Responses in an Asthma Model
by: Paiboon Jungsuwadee, et al.
Published: (2012-08-01) -
The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues
by: Shashank Shrishrimal, et al.
Published: (2017-11-01) -
Superoxide dismutase mimic, MnTE-2-PyP5+ ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum
by: John O. Archambeau, et al.
Published: (2013-01-01) -
Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP5+
by: Benjamin Gauter-Fleckenstein, et al.
Published: (2014-01-01) -
Effects of MnTnHex-2-PyP on Lung Antioxidant Defence System in Asthma Mice Model
by: Violeta Dancheva, et al.
Published: (2012-12-01)